期刊文献+

符合治疗条件的HIV感染者/AIDS病人未接受HAART的影响因素 被引量:11

Influencing factors of HIV/AIDS patients eligible for HARRT but not receive antiretroviral treatment
原文传递
导出
摘要 高效抗反转录病毒治疗(HAART)目前已被证实是针对艾滋病病毒(HIV)感染的最有效的治疗方法。但目前符合治疗标准的HIV感染者和艾滋病(AIDS)病人接受治疗的比例并不高,其影响因素是多方面的,主要包括:病人认知程度低、服务提供有限、资金投入不足、社会歧视、服药本身不良反应和需终身服药等。为扩大治疗和提高覆盖率,建议:一要提高病人治疗积极性;二要减轻病人治疗负担;三要加强基层建设;四要营造良好的社会环境,减少和消除歧视。 It is confirmed that highly active antiretroviral therapy(HAART)is the most effective treatment for HIV infection now,but the proportion of treatment for eligible infected people is not high.The influence factors are various,mainly includes low cognitive level of patients,limited service,insufficient funding,social discrimination,drug toxicity and lifelong treatment.For expanding the treatment and increasing the coverage,four proposals are made: firstly,to improve the enthusiasm of patients;secondly,to reduce the burden of patients;thirdly,to strengthen the construction of grass-roots;and fourthly,to build a good social environment to reduce or eliminate discrimination.
作者 杨燕 刘中夫
出处 《中国艾滋病性病》 CAS 2013年第6期463-465,共3页 Chinese Journal of Aids & STD
关键词 艾滋病病毒感染者 艾滋病病人 抗病毒治疗 未接受治疗原因 覆盖率 AIDS/HIV HAART Causes of untreating Coverage
  • 相关文献

参考文献27

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:108
  • 2Rosen S,Fox M.Retention in HIV care between testing andtreatment in sub-Saharan Africa:A systematic review[J].PLoSMedicine,2011,8:e100105.
  • 3UNAIDS.UNAIDS report on the global AIDS epidemic[R].2012.
  • 4无.2011年中国艾滋病疫情估计[J].中国艾滋病性病,2012,18(1):1-5. 被引量:893
  • 5Shapiro MF,Morton SC,McCaffrey DF,et al.Variations in thecare of HIV-infected adults in the United States:Results from theHIV cost and services utilization study[J].JAMA,1999,281:2305-2315.
  • 6Wood E,Montaner JS,Bangsberg DR,et al.Expanding access toHIV antiretroviral therapy among marginalized populations in thedeveloped world[J].AIDS,2003,17:2419-2427.
  • 7Kigozi IM,Dobkin LM,Martin JN,et al.Late-disease stage atpresentation to an HIV clinic in the era of free antiretroviral ther-apy in Sub-Saharan Africa[J].J Acquir Immune Defic Syndr,2009,52:280-289.
  • 8May M,Boulle A,Phiri S,et al.Prognosis of patients with HIV-1infection starting antiretroviral therapy in sub-Saharan Africa:A collaborative analysis of scale-up programmes[J].Lancet,2010,376:449-457.
  • 9Rebolledo P,Kourbatova E,Rothenberg R,et al.Factors associ-ated with utilization of HAART amongst hard-to-reach HIV-in-fected individuals in Atlanta,Georgia[J].J AIDS HIV Res,2011,3:63-70.
  • 10金芳,白立石,李红霞,辛天义,任海英,周玲,曾毅.HIV/AIDS家庭社会心理状况调查[J].中国公共卫生,2007,23(9):1038-1039. 被引量:14

二级参考文献47

共引文献1070

同被引文献94

  • 1王晓琪,吴尊友.艾滋病患者药物治疗依从性及其影响因素和干预策略[J].中国艾滋病性病,2005,11(3):225-227. 被引量:28
  • 2王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:633
  • 3张福杰,汪宁.国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2005.12-79.
  • 4栾承,刘民.影响AIDS患者生存时间的因素研究[J].中国艾滋病性病,2007,13(5):489-491. 被引量:24
  • 5Smit C,Geskus R,Walker S,et al.Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion [J].AIDS,2006,20(5):741-749.
  • 6Costin JM.Cytopathic mechanisms of HIV-1 [J].Virol J,2007,18 (4): 100.
  • 7王书杰.艾滋病防控中卫生监督的工作重点[J].中国公共卫生管理,2007,23(6):524-525. 被引量:1
  • 8Johansson KA,Robberstad B,Northeim OF.Further benefits by early start of HIV treatment in Low income countries:survivaL estimates of earLy versus deferred antiretroviral therapy[J].AIDS Res Ther,2010,7(1):3.
  • 9Kitahata MM,Gange SJ,Abraham AG,et al.Effect of early versus deferred antiretroviral therapy for HIV on survivaL[J].N EngL J Med,2009,360(18):1815-1826.
  • 10Costin JM. Cytopathic mechanisms of HIV-1[J]. Virol J,2007,18(4):100.

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部